Loading…
Replacement of the Mouse LD50 Assay for Determination of the Potency of AbobotulinumtoxinA with a Cell-Based Method in Both Powder and Liquid Formulations
Botulinum neurotoxins (BoNTs) are important therapeutic agents. The in vivo median lethal dose (LD50) assay has been commonly used to measure the potency of BoNT commercial preparations. As an alternative, we developed cell-based assays for abobotulinumtoxinA in both powder (Dysport®, Azzalure®) and...
Saved in:
Published in: | Toxins 2023-04, Vol.15 (5), p.314 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c462t-8d62074fa5d377a024539fa1b189ee5dbbbf9f8ad9617524b2b71ef561cc34f33 |
---|---|
cites | cdi_FETCH-LOGICAL-c462t-8d62074fa5d377a024539fa1b189ee5dbbbf9f8ad9617524b2b71ef561cc34f33 |
container_end_page | |
container_issue | 5 |
container_start_page | 314 |
container_title | Toxins |
container_volume | 15 |
creator | Fonfria, Elena Marks, Elizabeth Foulkes, Lisa-Marie Schofield, Rebecca Higazi, Daniel Coward, Sam Kippen, Alistair |
description | Botulinum neurotoxins (BoNTs) are important therapeutic agents. The in vivo median lethal dose (LD50) assay has been commonly used to measure the potency of BoNT commercial preparations. As an alternative, we developed cell-based assays for abobotulinumtoxinA in both powder (Dysport®, Azzalure®) and liquid (Alluzience®) formulations using the in vitro BoCell® system. The assays demonstrated linearity over 50–130% of the expected relative potency, with a correlation coefficient of 0.98. Mean recoveries of 90–108% of the stated potency were observed over this range. The coefficients of variation for powder and liquid formulations, respectively, were 3.6% and 4.0% for repeatability and 8.3% and 5.0% for intermediate precision. A statistically powered comparability assessment of the BoCell® and LD50 assays was performed. Equivalence was demonstrated between the assays for the liquid formulation at release and end of shelf life using a paired equivalence test with predefined equivalence margins. For the powder formulation, the assays were also shown to be equivalent for release samples and when determining loss of potency following thermal degradation. The BoCell® assay was approved for establishing the potency of abobotulinumtoxinA for both powder and liquid formulations in Europe and for the powder formulation only in the USA. |
doi_str_mv | 10.3390/toxins15050314 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_3ffd446e80d14f4daed9b07ee3ec6b6d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_3ffd446e80d14f4daed9b07ee3ec6b6d</doaj_id><sourcerecordid>2820024104</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-8d62074fa5d377a024539fa1b189ee5dbbbf9f8ad9617524b2b71ef561cc34f33</originalsourceid><addsrcrecordid>eNpdkstuUzEQho8QiFalW9aW2LBJ8e3cVihNKVRKRYVgbfkybhydY6e2T0tehafFSQoieOPL_Ppm5vdU1VuCLxjr8YccfjqfSI1rzAh_UZ1S3NJZ09Tk5T_nk-o8pTUuizHSk_Z1dcJaymrG-9Pq1zfYDFLDCD6jYFFeAboNUwK0vKoxmqckt8iGiK4gQxydl9kF_0d5FzJ4vd1d5yqokKfB-Wnc1zVHTy6vkEQLGIbZpUxg0C3kVTDIeXQZSuwuPBmISHqDlu5hcgZdhzhOwz5HelO9snJIcP68n1U_rj99X3yZLb9-vlnMlzPNG5pnnWlKq9zK2rC2lZjymvVWEkW6HqA2Sinb206aviFtTbmiqiVg64Zozbhl7Ky6OXBNkGuxiW6UcSuCdGL_EOK9kDE7PYBg1hrOG-iwIdxyI8H0CrcADHSjGlNYHw-szaRGMLq4GuVwBD2OeLcS9-FREEwp7igvhPfPhBgeJkhZjC7pYqH0UP5F0I7i0iPBO-m7_6TrMEVfvCoq0vOOF2hRXRxUOoaUIti_1RAsdmMkjseI_QaVkLyD</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2819484022</pqid></control><display><type>article</type><title>Replacement of the Mouse LD50 Assay for Determination of the Potency of AbobotulinumtoxinA with a Cell-Based Method in Both Powder and Liquid Formulations</title><source>ProQuest - Publicly Available Content Database</source><source>PubMed Central</source><creator>Fonfria, Elena ; Marks, Elizabeth ; Foulkes, Lisa-Marie ; Schofield, Rebecca ; Higazi, Daniel ; Coward, Sam ; Kippen, Alistair</creator><creatorcontrib>Fonfria, Elena ; Marks, Elizabeth ; Foulkes, Lisa-Marie ; Schofield, Rebecca ; Higazi, Daniel ; Coward, Sam ; Kippen, Alistair</creatorcontrib><description>Botulinum neurotoxins (BoNTs) are important therapeutic agents. The in vivo median lethal dose (LD50) assay has been commonly used to measure the potency of BoNT commercial preparations. As an alternative, we developed cell-based assays for abobotulinumtoxinA in both powder (Dysport®, Azzalure®) and liquid (Alluzience®) formulations using the in vitro BoCell® system. The assays demonstrated linearity over 50–130% of the expected relative potency, with a correlation coefficient of 0.98. Mean recoveries of 90–108% of the stated potency were observed over this range. The coefficients of variation for powder and liquid formulations, respectively, were 3.6% and 4.0% for repeatability and 8.3% and 5.0% for intermediate precision. A statistically powered comparability assessment of the BoCell® and LD50 assays was performed. Equivalence was demonstrated between the assays for the liquid formulation at release and end of shelf life using a paired equivalence test with predefined equivalence margins. For the powder formulation, the assays were also shown to be equivalent for release samples and when determining loss of potency following thermal degradation. The BoCell® assay was approved for establishing the potency of abobotulinumtoxinA for both powder and liquid formulations in Europe and for the powder formulation only in the USA.</description><identifier>ISSN: 2072-6651</identifier><identifier>EISSN: 2072-6651</identifier><identifier>DOI: 10.3390/toxins15050314</identifier><identifier>PMID: 37235349</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Accuracy ; Assaying ; botulinum ; CBA ; Coefficient of variation ; Correlation coefficient ; Correlation coefficients ; Equivalence ; In vivo methods and tests ; LD50 ; Lethal dose ; Light ; Neurotoxins ; Pharmacology ; potency ; Powder ; Proteins ; replacement ; Shelf life ; Thermal degradation ; toxin ; Toxins</subject><ispartof>Toxins, 2023-04, Vol.15 (5), p.314</ispartof><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-8d62074fa5d377a024539fa1b189ee5dbbbf9f8ad9617524b2b71ef561cc34f33</citedby><cites>FETCH-LOGICAL-c462t-8d62074fa5d377a024539fa1b189ee5dbbbf9f8ad9617524b2b71ef561cc34f33</cites><orcidid>0000-0001-8816-519X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2819484022/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2819484022?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids></links><search><creatorcontrib>Fonfria, Elena</creatorcontrib><creatorcontrib>Marks, Elizabeth</creatorcontrib><creatorcontrib>Foulkes, Lisa-Marie</creatorcontrib><creatorcontrib>Schofield, Rebecca</creatorcontrib><creatorcontrib>Higazi, Daniel</creatorcontrib><creatorcontrib>Coward, Sam</creatorcontrib><creatorcontrib>Kippen, Alistair</creatorcontrib><title>Replacement of the Mouse LD50 Assay for Determination of the Potency of AbobotulinumtoxinA with a Cell-Based Method in Both Powder and Liquid Formulations</title><title>Toxins</title><description>Botulinum neurotoxins (BoNTs) are important therapeutic agents. The in vivo median lethal dose (LD50) assay has been commonly used to measure the potency of BoNT commercial preparations. As an alternative, we developed cell-based assays for abobotulinumtoxinA in both powder (Dysport®, Azzalure®) and liquid (Alluzience®) formulations using the in vitro BoCell® system. The assays demonstrated linearity over 50–130% of the expected relative potency, with a correlation coefficient of 0.98. Mean recoveries of 90–108% of the stated potency were observed over this range. The coefficients of variation for powder and liquid formulations, respectively, were 3.6% and 4.0% for repeatability and 8.3% and 5.0% for intermediate precision. A statistically powered comparability assessment of the BoCell® and LD50 assays was performed. Equivalence was demonstrated between the assays for the liquid formulation at release and end of shelf life using a paired equivalence test with predefined equivalence margins. For the powder formulation, the assays were also shown to be equivalent for release samples and when determining loss of potency following thermal degradation. The BoCell® assay was approved for establishing the potency of abobotulinumtoxinA for both powder and liquid formulations in Europe and for the powder formulation only in the USA.</description><subject>Accuracy</subject><subject>Assaying</subject><subject>botulinum</subject><subject>CBA</subject><subject>Coefficient of variation</subject><subject>Correlation coefficient</subject><subject>Correlation coefficients</subject><subject>Equivalence</subject><subject>In vivo methods and tests</subject><subject>LD50</subject><subject>Lethal dose</subject><subject>Light</subject><subject>Neurotoxins</subject><subject>Pharmacology</subject><subject>potency</subject><subject>Powder</subject><subject>Proteins</subject><subject>replacement</subject><subject>Shelf life</subject><subject>Thermal degradation</subject><subject>toxin</subject><subject>Toxins</subject><issn>2072-6651</issn><issn>2072-6651</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkstuUzEQho8QiFalW9aW2LBJ8e3cVihNKVRKRYVgbfkybhydY6e2T0tehafFSQoieOPL_Ppm5vdU1VuCLxjr8YccfjqfSI1rzAh_UZ1S3NJZ09Tk5T_nk-o8pTUuizHSk_Z1dcJaymrG-9Pq1zfYDFLDCD6jYFFeAboNUwK0vKoxmqckt8iGiK4gQxydl9kF_0d5FzJ4vd1d5yqokKfB-Wnc1zVHTy6vkEQLGIbZpUxg0C3kVTDIeXQZSuwuPBmISHqDlu5hcgZdhzhOwz5HelO9snJIcP68n1U_rj99X3yZLb9-vlnMlzPNG5pnnWlKq9zK2rC2lZjymvVWEkW6HqA2Sinb206aviFtTbmiqiVg64Zozbhl7Ky6OXBNkGuxiW6UcSuCdGL_EOK9kDE7PYBg1hrOG-iwIdxyI8H0CrcADHSjGlNYHw-szaRGMLq4GuVwBD2OeLcS9-FREEwp7igvhPfPhBgeJkhZjC7pYqH0UP5F0I7i0iPBO-m7_6TrMEVfvCoq0vOOF2hRXRxUOoaUIti_1RAsdmMkjseI_QaVkLyD</recordid><startdate>20230429</startdate><enddate>20230429</enddate><creator>Fonfria, Elena</creator><creator>Marks, Elizabeth</creator><creator>Foulkes, Lisa-Marie</creator><creator>Schofield, Rebecca</creator><creator>Higazi, Daniel</creator><creator>Coward, Sam</creator><creator>Kippen, Alistair</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T7</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PATMY</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PYCSY</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8816-519X</orcidid></search><sort><creationdate>20230429</creationdate><title>Replacement of the Mouse LD50 Assay for Determination of the Potency of AbobotulinumtoxinA with a Cell-Based Method in Both Powder and Liquid Formulations</title><author>Fonfria, Elena ; Marks, Elizabeth ; Foulkes, Lisa-Marie ; Schofield, Rebecca ; Higazi, Daniel ; Coward, Sam ; Kippen, Alistair</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-8d62074fa5d377a024539fa1b189ee5dbbbf9f8ad9617524b2b71ef561cc34f33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Accuracy</topic><topic>Assaying</topic><topic>botulinum</topic><topic>CBA</topic><topic>Coefficient of variation</topic><topic>Correlation coefficient</topic><topic>Correlation coefficients</topic><topic>Equivalence</topic><topic>In vivo methods and tests</topic><topic>LD50</topic><topic>Lethal dose</topic><topic>Light</topic><topic>Neurotoxins</topic><topic>Pharmacology</topic><topic>potency</topic><topic>Powder</topic><topic>Proteins</topic><topic>replacement</topic><topic>Shelf life</topic><topic>Thermal degradation</topic><topic>toxin</topic><topic>Toxins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fonfria, Elena</creatorcontrib><creatorcontrib>Marks, Elizabeth</creatorcontrib><creatorcontrib>Foulkes, Lisa-Marie</creatorcontrib><creatorcontrib>Schofield, Rebecca</creatorcontrib><creatorcontrib>Higazi, Daniel</creatorcontrib><creatorcontrib>Coward, Sam</creatorcontrib><creatorcontrib>Kippen, Alistair</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Environmental Science Collection</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Toxins</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fonfria, Elena</au><au>Marks, Elizabeth</au><au>Foulkes, Lisa-Marie</au><au>Schofield, Rebecca</au><au>Higazi, Daniel</au><au>Coward, Sam</au><au>Kippen, Alistair</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Replacement of the Mouse LD50 Assay for Determination of the Potency of AbobotulinumtoxinA with a Cell-Based Method in Both Powder and Liquid Formulations</atitle><jtitle>Toxins</jtitle><date>2023-04-29</date><risdate>2023</risdate><volume>15</volume><issue>5</issue><spage>314</spage><pages>314-</pages><issn>2072-6651</issn><eissn>2072-6651</eissn><abstract>Botulinum neurotoxins (BoNTs) are important therapeutic agents. The in vivo median lethal dose (LD50) assay has been commonly used to measure the potency of BoNT commercial preparations. As an alternative, we developed cell-based assays for abobotulinumtoxinA in both powder (Dysport®, Azzalure®) and liquid (Alluzience®) formulations using the in vitro BoCell® system. The assays demonstrated linearity over 50–130% of the expected relative potency, with a correlation coefficient of 0.98. Mean recoveries of 90–108% of the stated potency were observed over this range. The coefficients of variation for powder and liquid formulations, respectively, were 3.6% and 4.0% for repeatability and 8.3% and 5.0% for intermediate precision. A statistically powered comparability assessment of the BoCell® and LD50 assays was performed. Equivalence was demonstrated between the assays for the liquid formulation at release and end of shelf life using a paired equivalence test with predefined equivalence margins. For the powder formulation, the assays were also shown to be equivalent for release samples and when determining loss of potency following thermal degradation. The BoCell® assay was approved for establishing the potency of abobotulinumtoxinA for both powder and liquid formulations in Europe and for the powder formulation only in the USA.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>37235349</pmid><doi>10.3390/toxins15050314</doi><orcidid>https://orcid.org/0000-0001-8816-519X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2072-6651 |
ispartof | Toxins, 2023-04, Vol.15 (5), p.314 |
issn | 2072-6651 2072-6651 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_3ffd446e80d14f4daed9b07ee3ec6b6d |
source | ProQuest - Publicly Available Content Database; PubMed Central |
subjects | Accuracy Assaying botulinum CBA Coefficient of variation Correlation coefficient Correlation coefficients Equivalence In vivo methods and tests LD50 Lethal dose Light Neurotoxins Pharmacology potency Powder Proteins replacement Shelf life Thermal degradation toxin Toxins |
title | Replacement of the Mouse LD50 Assay for Determination of the Potency of AbobotulinumtoxinA with a Cell-Based Method in Both Powder and Liquid Formulations |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A49%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Replacement%20of%20the%20Mouse%20LD50%20Assay%20for%20Determination%20of%20the%20Potency%20of%20AbobotulinumtoxinA%20with%20a%20Cell-Based%20Method%20in%20Both%20Powder%20and%20Liquid%20Formulations&rft.jtitle=Toxins&rft.au=Fonfria,%20Elena&rft.date=2023-04-29&rft.volume=15&rft.issue=5&rft.spage=314&rft.pages=314-&rft.issn=2072-6651&rft.eissn=2072-6651&rft_id=info:doi/10.3390/toxins15050314&rft_dat=%3Cproquest_doaj_%3E2820024104%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c462t-8d62074fa5d377a024539fa1b189ee5dbbbf9f8ad9617524b2b71ef561cc34f33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2819484022&rft_id=info:pmid/37235349&rfr_iscdi=true |